Medical Condition News RSS Feed - Medical Condition News

Scientists use Regeneration Intelligence to assess perturbation status of many signaling pathways

Scientists use Regeneration Intelligence to assess perturbation status of many signaling pathways

Insilico Medicine, Inc in collaboration with scientists from Atlas Regeneration, Inc, Vision Genomics, Inc and Howard University published two research papers on fibrosis in the lung and liver and fibrotic signatures in glaucoma. [More]
Lisinopril oral solution approved for treatment of hypertension in children and adults

Lisinopril oral solution approved for treatment of hypertension in children and adults

Silvergate Pharmaceuticals, Inc., leader in the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration approved Qbrelis (Lisinopril) Oral Solution, the first and only FDA-approved Lisinopril oral solution. [More]
Kaiser Permanente telestroke program increases use of clot-dissolving treatment for stroke patients

Kaiser Permanente telestroke program increases use of clot-dissolving treatment for stroke patients

The use of a life-saving clot-dissolving treatment for patients with acute ischemic stroke increased by 73 percent following the implementation of a Kaiser Permanente telestroke program, according to a study published today in The Permanente Journal. [More]
USPTO grants key patent for Quark Pharmaceuticals' QPI-1007 ocular neuroprotectant

USPTO grants key patent for Quark Pharmaceuticals' QPI-1007 ocular neuroprotectant

Quark Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office has granted a key patent covering the treatment of patients suffering from non-arteritic anterior ischemic optic neuropathy ("NAION") with the Company's ocular neuroprotectant QPI-1007. [More]
Abingdon Health gains TGA regulatory approval for Seralite- FLC product in Australia

Abingdon Health gains TGA regulatory approval for Seralite- FLC product in Australia

Abingdon Health Ltd, is pleased to announce that it has gained regulatory approval by the Therapeutic Goods Administration in Australia for Seralite- FLC. [More]
Roche announces FDA approval of  new VENTANA PD-L1 assay

Roche announces FDA approval of new VENTANA PD-L1 assay

Roche today announced approval of the VENTANA PD-L1 (SP142) Assay by the US Food and Drug Administration as a complementary diagnostic to provide PD-L1 status on patients who are considering treatment with the FDA approved Roche immunotherapy TECENTRIQ™ (atezolizumab) for metastatic urothelial cancer (mUC). [More]
Research shows clear link between heart and the brain of LQTS patients

Research shows clear link between heart and the brain of LQTS patients

Researchers at the University of Rochester Medical Center recently discovered a genetic link between Long QT Syndrome (LQTS), a rare cardiac rhythm disease, and an increased risk for seizures. [More]
Study clarifies role of KLF12 in CRC tumor growth

Study clarifies role of KLF12 in CRC tumor growth

Results of preclinical studies by MUSC investigators reported in the July 2016 issue of PLOS One, demonstrate for the first time that the transcription factor KLF12 promotes CRC cell growth, in part, by activating EGR1. Furthermore, data demonstrate that KLF12 and EGR1 levels synergistically correlate with poor CRC prognoses. [More]
Northwell Health receives grant to assess pulmonary rehabilitation via telehealth for Hispanic COPD patients

Northwell Health receives grant to assess pulmonary rehabilitation via telehealth for Hispanic COPD patients

Northwell Health's Feinstein Institute for Medical Research has been awarded a $1.5 million grant from the Patient-Centered Outcomes Research Institute to study whether home-based pulmonary rehabilitation improves quality of life and decreases hospitalization in Hispanic patients with moderate to severe chronic obstructive pulmonary disease (COPD). [More]
Triple-combination therapy patch shrinks tumors, prevents recurrence in colon cancer mice model

Triple-combination therapy patch shrinks tumors, prevents recurrence in colon cancer mice model

Investigators at Brigham and Women's Hospital have developed a hydrogel patch that can adhere to tumors in a preclinical model of colon cancer, delivering a local, combination treatment as the elastic gel breaks down over time. [More]
Smoking reduces lifespans and overall chances of kidney transplantation in dialysis patients

Smoking reduces lifespans and overall chances of kidney transplantation in dialysis patients

Dialysis patients who smoke are much less likely to receive a life-saving kidney transplant and much more likely to die sooner according to researchers from the Health Research Institute (HRI) at the University of Limerick and UL’s Graduate Entry Medical School. [More]
Scientists make a big leap on mini-brain research

Scientists make a big leap on mini-brain research

Scientists in Singapore have made a big leap on research on the 'mini-brain'. These advanced mini versions of the human midbrain will help researchers develop treatments and conduct other studies into Parkinson's Disease and ageing-related brain diseases. [More]
GSK, VentureWise partner to deliver independent educational program on COPD to GPs

GSK, VentureWise partner to deliver independent educational program on COPD to GPs

A new agreement between GlaxoSmithKline and VentureWise—part of the MedicineWise Group—will see an independent educational program delivered to GPs on the topic of chronic obstructive pulmonary disease. [More]
Study supports removing transgender identity from WHO International Classification of Diseases

Study supports removing transgender identity from WHO International Classification of Diseases

New evidence suggests that it would be appropriate to remove the diagnosis of transgender from its current classification as a mental disorder, according to a study conducted in Mexico City. [More]
SAPIEN 3 trans-catheter aortic valve replacement system improves survival in patients with aortic stenosis

SAPIEN 3 trans-catheter aortic valve replacement system improves survival in patients with aortic stenosis

Overall one-year survival was over 85 percent for high-risk or inoperable patients who underwent aortic valve replacement with the SAPIEN 3 trans-catheter aortic valve replacement system, according to a study published in the July 12 issue of the American Heart Association journal Circulation. [More]
One in four dermatology nurses likely to be the only regular home visitor for patients, survey reveals

One in four dermatology nurses likely to be the only regular home visitor for patients, survey reveals

Almost one in four nurses reported that they were likely to be the only regular visitor for around half of the patients they see at home in a recent survey by the British Skin Foundation. [More]
Novel method sheds light on how disruption in LRRK2 gene causes inherited Parkinson's disease

Novel method sheds light on how disruption in LRRK2 gene causes inherited Parkinson's disease

Scientists have developed a new method of measuring the activity of disease-causing mutations in the LRRK2 gene, a major cause of inherited Parkinson's disease. [More]
Headache and migraine sufferers asked to self manage treatment as part of new Griffith research

Headache and migraine sufferers asked to self manage treatment as part of new Griffith research

Headache and migraine sufferers are being asked to self manage their own treatment as part of new research at Griffith University. [More]
Deafblind people face health inequalities and barriers in accessing healthcare in England

Deafblind people face health inequalities and barriers in accessing healthcare in England

A report published today by the national deafblind charity, Sense, highlights the health inequalities and barriers faced by deafblind people accessing healthcare in England. [More]
Research could help clinicians identify patients who may benefit from targeted therapy for liver cancer

Research could help clinicians identify patients who may benefit from targeted therapy for liver cancer

New research from Roswell Park Cancer Institute offers clinicians treating patients with advanced liver cancer a way of determining which patients may benefit most from the targeted therapy sorafenib. [More]
Advertisement
Advertisement